Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

BNT162b2-induced memory T cells respond to the Omicron variant with preserved polyfunctionality
Min Kyung Jung, Seong Dong Jeong, Ji Yun Noh, et al.
Nature Microbiology (2022) Vol. 7, Iss. 6, pp. 909-917
Open Access | Times Cited: 54

Showing 1-25 of 54 citing articles:

SARS-CoV-2-specific T cells in the changing landscape of the COVID-19 pandemic
Antonio Bertoletti, Nina Le Bert, Anthony T. Tan
Immunity (2022) Vol. 55, Iss. 10, pp. 1764-1778
Open Access | Times Cited: 92
Durability of Vaccine-Induced and Natural Immunity Against COVID-19: A Narrative Review
Nick Pooley, Salim S. Abdool Karim, Béhazine Combadière, et al.
Infectious Diseases and Therapy (2023) Vol. 12, Iss. 2, pp. 367-387
Open Access | Times Cited: 63
Vaccine adjuvants: Tailoring innate recognition to send the right message
Ed C. Lavelle, Craig P. McEntee
Immunity (2024) Vol. 57, Iss. 4, pp. 772-789
Open Access | Times Cited: 14
A comparative characterization of SARS-CoV-2-specific T cells induced by mRNA or inactive virus COVID-19 vaccines
Joey Ming Er Lim, Shou Kit Hang, Smrithi Hariharaputran, et al.
Cell Reports Medicine (2022) Vol. 3, Iss. 11, pp. 100793-100793
Open Access | Times Cited: 54
Defending against SARS-CoV-2: The T cell perspective
Patricia Almendro-Vázquez, Rocío Laguna‐Goya, Estela Paz‐Artal
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 36
Hybrid Immunity to SARS-CoV-2 from Infection and Vaccination—Evidence Synthesis and Implications for New COVID-19 Vaccines
Júlia Spinardi, Amit Srivastava
Biomedicines (2023) Vol. 11, Iss. 2, pp. 370-370
Open Access | Times Cited: 32
T cell immune memory after covid-19 and vaccination
Lulu Wang, Alexander R. Nicols, Lance Turtle, et al.
BMJ Medicine (2023) Vol. 2, Iss. 1, pp. e000468-e000468
Open Access | Times Cited: 25
SARS-CoV-2: Immunity, Challenges with Current Vaccines, and a Novel Perspective on Mucosal Vaccines
Raju Sunagar, Amit Kumar Singh, Sudeep Kumar
Vaccines (2023) Vol. 11, Iss. 4, pp. 849-849
Open Access | Times Cited: 23
SARS-CoV-2-specific CD4+ and CD8+ T cell responses can originate from cross-reactive CMV-specific T cells
Cilia R. Pothast, Romy C. Dijkland, Melissa Thaler, et al.
eLife (2022) Vol. 11
Open Access | Times Cited: 29
Persistent T cell-mediated immune responses against Omicron variants after the third COVID-19 mRNA vaccine dose
Milja Belik, Oona Liedes, Saimi Vara, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 18
Antigen‐specific and cross‐reactive T cells in protection and disease
Ning Jiang, Michael Malone, Shahab Chizari
Immunological Reviews (2023) Vol. 316, Iss. 1, pp. 120-135
Closed Access | Times Cited: 16
Omicron BA.2 breakthrough infection elicits CD8 + T cell responses recognizing the spike of later Omicron subvariants
Sang-Hoon Kim, Jihye Kim, Sungmin Jung, et al.
Science Immunology (2024) Vol. 9, Iss. 91
Closed Access | Times Cited: 5
Virus-specific T cell response in SARS-CoV-2 infection and vaccinations
Antonio Bertoletti, Martin Qui, Joey Ming Er Lim
Elsevier eBooks (2025), pp. 191-206
Closed Access
Psychological booster shots targeting memory increase long-term resistance against misinformation
Rakoen Maertens, Jon Roozenbeek, Jon S. Simons, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Omicron variants breakthrough infection elicited higher specific memory immunity than third dose booster in healthy vaccinees
Pei Yu, Zijian Liu, Zhuoqi Zhu, et al.
Virologica Sinica (2023) Vol. 38, Iss. 2, pp. 233-243
Open Access | Times Cited: 12
Psychological Booster Shots Targeting Memory Increase Long-Term Resistance Against Misinformation
Rakoen Maertens, Jon Roozenbeek, Jon S. Simons, et al.
(2023)
Open Access | Times Cited: 12
Comparative antibody and cell-mediated immune responses, reactogenicity, and efficacy of homologous and heterologous boosting with CoronaVac and BNT162b2 (Cobovax): an open-label, randomised trial
Nancy Leung, Samuel M. S. Cheng, Carolyn A. Cohen, et al.
The Lancet Microbe (2023) Vol. 4, Iss. 9, pp. e670-e682
Open Access | Times Cited: 10
Longitudinal cellular and humoral immune responses after triple BNT162b2 and fourth full-dose mRNA-1273 vaccination in haemodialysis patients
Matthias Becker, Anne Cossmann, Karsten Lürken, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 17
The deciphering of the immune cells and marker signature in COVID‐19 pathogenesis: An update
Saade Abdalkareem Jasim, Roaa Salih Mahdi, Dmitry Olegovich Bokov, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 11, pp. 5128-5148
Open Access | Times Cited: 16
The Function of Memory CD8+ T Cells in Immunotherapy for Human Diseases
Hanbyeul Choi, Yeaji Kim, Yong Woo Jung
Immune Network (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 9
Adenoviral-vectored next-generation respiratory mucosal vaccines against COVID-19
Sam Afkhami, Alisha Kang, Vidthiya Jeyanathan, et al.
Current Opinion in Virology (2023) Vol. 61, pp. 101334-101334
Open Access | Times Cited: 9
Omicron Subvariants, Including BA.4 and BA.5, Substantially Preserve T Cell Epitopes of Ancestral SARS-CoV-2
Kyemyung Park, Seong Jin Choi, Eui‐Cheol Shin
Immune Network (2022) Vol. 22, Iss. 4
Open Access | Times Cited: 14
Immune responses related to the immunogenicity and reactogenicity of COVID-19 mRNA vaccines
Takayuki Matsumura, Tomohiro Takano, Yoshimasa Takahashi
International Immunology (2022) Vol. 35, Iss. 5, pp. 213-220
Open Access | Times Cited: 14
Safety, immunogenicity and efficacy of an mRNA-based COVID-19 vaccine, GLB-COV2-043, in preclinical animal models
Felipe Lelis, Laura A. Byk, Sergei Pustylnikov, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 8
Antibody and T cell responses against wild-type and Omicron SARS-CoV-2 after third-dose BNT162b2 in adolescents
Xiaofeng Mu, Carolyn A. Cohen, Daniel Leung, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 13
Page 1 - Next Page

Scroll to top